Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Satellos Bioscience Inc
T.MSCL
Alternate Symbol(s):
MSCLF
Healthcare
Biotechnology
Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this...
process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:MSCL)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
Next
(75)
•••
db2067
X
View Profile
View Bullboard History
Post by
db2067
on Nov 25, 2021 9:12pm
Severe covid-19 pill form medication
I am not seeing any successful pill form medication for moderate to severe cases of Covid-19 - Merck / Pfizer are for early stage - they need to get people started with-in a few days. Skymount medical
...more
(23)
•••
blinkie
X
View Profile
View Bullboard History
Post by
blinkie
on Nov 25, 2021 4:29pm
Why do we hear positive news from db2067 & not from thr PR f
If I was signing these guys cheques I would be Adkin myself that !!!
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(75)
•••
db2067
X
View Profile
View Bullboard History
Post by
db2067
on Nov 25, 2021 11:43am
Satellos' muscle regeneration therapy...
Check out this paper, exciting work here, this is a much higher level of validation than traditional animal models - things are moving ahead quickly with Satellos' muscle regeneration therapy
...more
(23)
•••
blinkie
X
View Profile
View Bullboard History
Post by
blinkie
on Nov 23, 2021 11:54am
Where is the news?
There must be something positive they can come up with
(23)
•••
blinkie
X
View Profile
View Bullboard History
Post by
blinkie
on Nov 18, 2021 5:07pm
Hard To Belive Stellios Can Be So Stupid,
Their takeover was actually 'brilliant' and now they allow this. they should be embarassed
(303)
•••
beenthere
X
View Profile
View Bullboard History
Comment by
beenthere
on Nov 18, 2021 4:36pm
RE:BND
I am sure you meant to say $1.20 lol Well at least reverse splits follow the same patterns! From 10.5 to 6 pennies in such a short time! Wow! When do we see Part 2? You know ... Part 2 ... doing a
...more
(28)
•••
Drambuey
X
View Profile
View Bullboard History
Post by
Drambuey
on Nov 18, 2021 12:09pm
BND
$1.28 and it only cost $10,000 can't wait to see next month's results
(9)
•••
Itistoo
X
View Profile
View Bullboard History
Comment by
Itistoo
on Nov 13, 2021 8:14pm
RE:BND Projects Inc.
1 month isn't up yet so we'll see what happens. Its been about 8 months of being in the dark with this company. It is my hope that they will have a string of announcements coming sooner than
...more
(28)
•••
Drambuey
X
View Profile
View Bullboard History
Post by
Drambuey
on Nov 12, 2021 6:23pm
BND Projects Inc.
So on October 27 it was annouced that BND Projects Inc. at a cost of $10,000 per month, would be on the job and in charge of investor relations and on that day the stock closed at $1.50.
...more
(12)
•••
Cautus99
X
View Profile
View Bullboard History
Post by
Cautus99
on Sep 24, 2021 12:12pm
Starting to move up
Nice to see the increases the past 2 days.
(19)
•••
Smiles62
X
View Profile
View Bullboard History
Comment by
Smiles62
on Sep 23, 2021 3:22pm
RE:RE:Skymount Medical
When it bounces....
(9)
•••
Itistoo
X
View Profile
View Bullboard History
Comment by
Itistoo
on Sep 22, 2021 7:10pm
RE:$1.28 = .06
I really hope the start releasing some promising information soon.. So far it seems like their plan is to tank the sp.
(28)
•••
Drambuey
X
View Profile
View Bullboard History
Post by
Drambuey
on Sep 22, 2021 10:24am
$1.28 = .06
Glad to see this is working out so well for us, time for management bonuses LOL
(19)
•••
Smiles62
X
View Profile
View Bullboard History
Comment by
Smiles62
on Sep 21, 2021 9:22am
RE:Skymount Medical
The ask is now at 1.25, it's obvious that there is no new money coming into this stock, just the market makers playing it now. They are working it to get current SH discouraged, and they pick up.
(75)
•••
db2067
X
View Profile
View Bullboard History
Post by
db2067
on Sep 19, 2021 12:47pm
Skymount Medical
Page 49 of the June 24, 2021 Satellos / iCo Therapeutics PROPOSED PLAN OF ARRANGEMENT "iCo is currently exploring partnering options and pursuing funding sources to initiate its
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden